CL vs MDLZ
Colgate-Palmolive and Mondelez International, both Consumer Defensive
Mondelez International is the larger company at $79B against $72B. On trailing earnings MDLZ is the cheaper of the two at a P/E of 30.6 against 35.6, a gap that is only a bargain if the two are growing at similar rates. Over the past year CL returned +13% against -0.5% for MDLZ. The RyuScore puts CL ahead, 74 against 62 out of 100.
| Figure | CL | MDLZ |
|---|---|---|
| Last close | $89.98 | $61.80 |
| Market cap | $72B | $79B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 35.6 | 30.6 |
| Dividend yield | 2.3% | 3.1% |
| 1-year return | +13% | -0.5% |
| 5-year return | +30% | +16% |
| RyuScoresector-relative, 1–10 | 74/100 | 62/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Colgate-Palmolive
Revenue of $5.4B in Q2 2026, net income $693M. Its largest reported line is Latin America, 33% of the disclosed total.
Mondelez International
Revenue of $10B in Q1 2026, net income $560M. Its largest reported line is Gum And Candy, 32% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.